Literature DB >> 18758786

Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings.

Laurent Lemaitre1, Philippe Puech, Edouard Poncelet, Sébastien Bouyé, Xavier Leroy, Jacques Biserte, Arnauld Villers.   

Abstract

The purpose of the study was to relate morphometric features of prostate cancers in the anterior compartment of the prostate by dynamic contrast-enhanced (DCE) MRI to subsequent histopathologic findings. We prospectively performed DCE-MRI before biopsy in patients with suspected prostate cancer and selected those showing both a suspicious lesion at MRI and positive biopsies in the anterior compartment of the gland. Tumor contours, margins, largest surface areas and volumes were assessed at MRI and histopathology, when available. Anterior compartment tumors were classified according to transition zone (TZ) boundaries with the peripheral zone (PZ) or with the anterior fibromuscular stroma (SFMA). Forty-three patients were included in this study [median PSA 12.7 ng/ml (3.6-72)]. Whole-mount radical prostatectomy specimens were available in 27 cases. Of the anterior cancers, 89% had ill-defined margins at T2-weighted MRI. Cancer location and contour established at MRI agreed well with histopathology in the 27 cases. Median largest surface area and volume were 1.38 cm(2) (0.35-5.82) and 1.01 cc (0.15-7.4) for MRI versus 1.86 cm(2) (0.2-14) and 2.84 cc (0.33-28.92) for histopathology with respective correlation coefficients (r(2)) of 0.73 and 0.69. The site of origin could be accurately determined for the 15 tumors of less than 3 cc. We found a good relationship between DCE-MRI and histopathology for localization, morphologic description and volume assessment of anterior prostate cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758786     DOI: 10.1007/s00330-008-1153-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

1.  MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla.

Authors:  Jacob Sosna; Ivan Pedrosa; William C Dewolf; Houman Mahallati; Robert E Lenkinski; Neil M Rofsky
Journal:  Acad Radiol       Date:  2004-08       Impact factor: 3.173

2.  Prostate cancer computer-assisted diagnosis software using dynamic contrast-enhanced MRI.

Authors:  Philippe Puech; Nacim Betrouni; Romain Viard; Arnauld Villers; Xavier Leroy; Laurent Lemaitre
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2007

3.  Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate.

Authors:  Chiho Sato; Shinji Naganawa; Tatsuya Nakamura; Hisashi Kumada; Shunichi Miura; Osamu Takizawa; Takeo Ishigaki
Journal:  J Magn Reson Imaging       Date:  2005-03       Impact factor: 4.813

4.  Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens.

Authors:  T A Stamey; C M Yemoto; J E McNeal; B M Sigal; I M Johnstone
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

5.  Patterns of spread of adenocarcinoma in the prostate as related to cancer volume.

Authors:  J E McNeal; O Haillot
Journal:  Prostate       Date:  2001-09-15       Impact factor: 4.104

6.  Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.

Authors:  Oguz Akin; Evis Sala; Chaya S Moskowitz; Kentaro Kuroiwa; Nicole M Ishill; Darko Pucar; Peter T Scardino; Hedvig Hricak
Journal:  Radiology       Date:  2006-03-28       Impact factor: 11.105

7.  Origin and racial distribution of glandular tissue in the anterior compartment of the prostate: an autopsy study.

Authors:  R Tiguert; W Kabbani; W Sakr; E L Gheiler; J E Pontes
Journal:  Prostate       Date:  1999-06-01       Impact factor: 4.104

Review 8.  How good is MRI at detecting and characterising cancer within the prostate?

Authors:  Alexander P S Kirkham; Mark Emberton; Clare Allen
Journal:  Eur Urol       Date:  2006-06-30       Impact factor: 20.096

9.  The value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostate.

Authors:  T Namimoto; S Morishita; R Saitoh; J Kudoh; Y Yamashita; M Takahashi
Journal:  Comput Med Imaging Graph       Date:  1998 May-Jun       Impact factor: 4.790

10.  Differences in biopsy features between prostate cancers located in the transition and peripheral zone.

Authors:  H Augustin; A Erbersdobler; M Graefen; T Jaekel; A Haese; H Huland; P G Hammerer
Journal:  BJU Int       Date:  2003-04       Impact factor: 5.588

View more
  35 in total

1.  Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.

Authors:  Hashim U Ahmed; Oguz Akin; Jonathan A Coleman; Sarah Crane; Mark Emberton; Larry Goldenberg; Hedvig Hricak; Mike W Kattan; John Kurhanewicz; Caroline M Moore; Chris Parker; Thomas J Polascik; Peter Scardino; Nicholas van As; Arnauld Villers
Journal:  BJU Int       Date:  2011-11-11       Impact factor: 5.588

2.  Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?

Authors:  Richard Hoffmann; Callum Logan; Michael O'Callaghan; Kirsten Gormly; Ken Chan; Darren Foreman
Journal:  Int Urol Nephrol       Date:  2017-11-29       Impact factor: 2.370

Review 3.  Optimum slicing of radical prostatectomy specimens for correlation between histopathology and medical images.

Authors:  Li Hong Chen; Henry Ho; Richie Lazaro; Choon Hua Thng; John Yuen; Wan Sing Ng; Chris Cheng
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-02-24       Impact factor: 2.924

4.  Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.

Authors:  Chau Hung Lee; Balamurugan Vellayappan; Matthias Taupitz; Bernd Hamm; Patrick Asbach
Journal:  Eur Radiol       Date:  2019-07-01       Impact factor: 5.315

5.  Diagnosis of transition zone prostate cancer using T2-weighted (T2W) MRI: comparison of subjective features and quantitative shape analysis.

Authors:  Satheesh Krishna; Nicola Schieda; Matthew Df McInnes; Trevor A Flood; Rebecca E Thornhill
Journal:  Eur Radiol       Date:  2018-08-13       Impact factor: 5.315

Review 6.  Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management.

Authors:  Sadhna Verma; Baris Turkbey; Naira Muradyan; Arumugam Rajesh; Francois Cornud; Masoom A Haider; Peter L Choyke; Mukesh Harisinghani
Journal:  AJR Am J Roentgenol       Date:  2012-06       Impact factor: 3.959

Review 7.  Multiparametric MRI in prostate cancer management.

Authors:  Linda M Johnson; Baris Turkbey; William D Figg; Peter L Choyke
Journal:  Nat Rev Clin Oncol       Date:  2014-05-20       Impact factor: 66.675

8.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.

Authors:  Flavie Bratan; Emilie Niaf; Christelle Melodelima; Anne Laure Chesnais; Rémi Souchon; Florence Mège-Lechevallier; Marc Colombel; Olivier Rouvière
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

Review 9.  Imaging techniques for prostate cancer: implications for focal therapy.

Authors:  Baris Turkbey; Peter A Pinto; Peter L Choyke
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

Review 10.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.